FDA Orders New Vision Loss Warnings for GLP-1 Drugs
The FDA has mandated new warning labels for popular GLP-1 drugs including Ozempic and Wegovy due to reports of a rare eye condition.
Results for “non-arteritic anterior ischemic optic neuropathy”
1 story found.